GR138676 [3777]
GR138676
| SMILES | CSCC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CC[C@@H]2CN([C@H](CC(C)C)C(=O)NC(COCc3ccccc3)COCc3ccccc3)C(=O)[C@@H]21 |
| InChIKey | SHZVIDXXKGEHEF-QEPUNBJPSA-N |
| Sequence | DMHDFFF |
Chemical Properties
| Hydrogen bond acceptors | 16 |
| Hydrogen bond donors | 11 |
| Rotatable bonds | 41 |
| Log P | 3.011 |
| Molecular weight (Da) | 1432.7 |
| Stereochemistry info | partial |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
GR138676
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0